Danaher Corporation (DHR) - Total Liabilities
Based on the latest financial reports, Danaher Corporation (DHR) has total liabilities worth $28.83 Billion USD as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore DHR year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Danaher Corporation - Total Liabilities Trend (1985–2024)
This chart illustrates how Danaher Corporation's total liabilities have evolved over time, based on quarterly financial data. See cash generation quality of Danaher Corporation to measure how efficiently the company converts operating cash flow to free cash.
Danaher Corporation Competitors by Total Liabilities
The table below lists competitors of Danaher Corporation ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Pfizer Inc
NYSE:PFE
|
USA | $117.21 Billion |
|
ALLIANZ SE UNSP.ADR 1/10
F:ALVE
|
Germany | €957.93 Billion |
|
ConocoPhillips
NYSE:COP
|
USA | $58.18 Billion |
|
Allianz SE VNA O.N.
XETRA:ALV
|
Germany | €949.07 Billion |
|
Airbus SE
F:AIRA
|
Germany | €112.52 Billion |
|
Airbus Group SE
PA:AIR
|
France | €108.91 Billion |
|
Booking Holdings Inc
NASDAQ:BKNG
|
USA | $36.44 Billion |
|
Eaton Corporation PLC
NYSE:ETN
|
USA | $21.77 Billion |
Liability Composition Analysis (1985–2024)
This chart breaks down Danaher Corporation's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see DHR company net worth.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.52 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 0.24 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.56 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.36 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Danaher Corporation's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Danaher Corporation (1985–2024)
The table below shows the annual total liabilities of Danaher Corporation from 1985 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $27.99 Billion | -9.70% |
| 2023-12-31 | $31.00 Billion | -9.52% |
| 2022-12-31 | $34.26 Billion | -9.86% |
| 2021-12-31 | $38.01 Billion | +4.46% |
| 2020-12-31 | $36.38 Billion | +14.42% |
| 2019-12-31 | $31.80 Billion | +62.20% |
| 2018-12-31 | $19.61 Billion | -3.33% |
| 2017-12-31 | $20.28 Billion | -8.72% |
| 2016-12-31 | $22.22 Billion | -9.16% |
| 2015-12-31 | $24.46 Billion | +80.61% |
| 2014-12-31 | $13.54 Billion | +10.81% |
| 2013-12-31 | $12.22 Billion | -11.81% |
| 2012-12-31 | $13.86 Billion | +6.78% |
| 2011-12-31 | $12.98 Billion | +53.68% |
| 2010-12-31 | $8.44 Billion | +6.02% |
| 2009-12-31 | $7.97 Billion | +3.69% |
| 2008-12-31 | $7.68 Billion | -8.40% |
| 2007-12-31 | $8.39 Billion | +34.84% |
| 2006-12-31 | $6.22 Billion | +52.34% |
| 2005-12-31 | $4.08 Billion | +5.38% |
| 2004-12-31 | $3.87 Billion | +19.45% |
| 2003-12-31 | $3.24 Billion | +7.41% |
| 2002-12-31 | $3.02 Billion | +16.50% |
| 2001-12-31 | $2.59 Billion | +24.05% |
| 2000-12-31 | $2.09 Billion | +56.12% |
| 1999-12-31 | $1.34 Billion | -3.50% |
| 1998-12-31 | $1.39 Billion | +44.05% |
| 1997-12-31 | $962.80 Million | -0.21% |
| 1996-12-31 | $964.80 Million | +7.24% |
| 1995-12-31 | $899.70 Million | +36.57% |
| 1994-12-31 | $658.80 Million | +29.48% |
| 1993-12-31 | $508.80 Million | +20.74% |
| 1992-12-31 | $421.40 Million | +1.37% |
| 1991-12-31 | $415.70 Million | -5.42% |
| 1990-12-31 | $439.50 Million | +39.30% |
| 1989-12-31 | $315.50 Million | -24.90% |
| 1988-12-31 | $420.10 Million | -23.89% |
| 1987-12-31 | $552.00 Million | -18.28% |
| 1986-12-31 | $675.50 Million | +208.45% |
| 1985-12-31 | $219.00 Million | -- |
About Danaher Corporation
Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. It operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment provides bioprocessing technologies, consumables, services, and solutions that advance, accelerate, and integrate the deve… Read more